Rory Collins
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management 2
-
- Antiplatelet Therapy and Cardiovascular Diseases 2
- Cardiac, Anesthesia and Surgical Outcomes 1
- Pharmacy top 0.5%
- Physiology top 2%
-
- Health Systems, Economic Evaluations, Quality of Life 3
-
- Meta-analysis and systematic reviews 2
-
- Lipoproteins and Cardiovascular Health 2
-
- Cerebrovascular and Carotid Artery Diseases 2
-
- Acute Ischemic Stroke Management 1
Rory Collins
10 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Internal Medicine 919
- Cardiology and Cardiovascular Medicine 2.0k
- Pharmacy 408
- Physiology 1.2k
- Endocrinology, Diabetes and Metabolism 788
Countries citing papers authored by Rory Collins
This map shows the geographic impact of Rory Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rory Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rory Collins more than expected).
Fields of papers citing papers by Rory Collins
This network shows the impact of papers produced by Rory Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rory Collins. The network helps show where Rory Collins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rory Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 52 | |
| 2 | Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studiesbreakdown → | 2009 | 3418 |
| 3 | 2005 | 86 | |
| 4 | Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditionsbreakdown → | 2004 | 749 |
| 5 | 2001 | 174 | |
| 6 | 2000 | 284 | |
| 7 | 1997 | 34 | |
| 8 | 1997 | 189 | |
| 9 | 1995 | 234 | |
| 10 | Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparinbreakdown → | 1988 | 981 |
About Rory Collins
Rory Collins is a scholar working on Internal Medicine, Statistics, Probability and Uncertainty and Cardiology and Cardiovascular Medicine, having authored 10 papers that have together received 6.2k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Meta-analysis and systematic reviews (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Cerebrovascular and Carotid Artery Diseases (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Cardiac, Anesthesia and Surgical Outcomes (1 paper) and Acute Ischemic Stroke Management (1 paper). The work is most often cited by research in Internal Medicine (919 citations), Cardiology and Cardiovascular Medicine (2.0k citations) and Pharmacy (408 citations). Rory Collins has collaborated with scholars based in United Kingdom, China and Australia. Frequent co-authors include Sarah Lewington, Gary Whitlock, Robert B. Clarke, Jonathan Emberson, Jim Halsey, Nawab Qizilbash, Paul Sherliker, Richárd Pető, Alison Scrimgeour and Salim Yusuf. Their work appears in journals such as The Lancet, New England Journal of Medicine, European Respiratory Journal, Journal of Clinical Epidemiology and Journal of Stroke and Cerebrovascular Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.